Susan C. Low

1 ta ish

Rodin Therapeutics (United States)

1. Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors

   Daniel D. Von Hoff, Monica Mita, Ramesh K. Ramanathan +11

   Maqola20162 iqtibos

   ABIABI:AkademIndex/2026.other.051860